Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Greenberg

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 7, 2025
Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosisShiv Saidha, John Kramer, Brandon Brown, et al.
BMC Bioinformatics|September 9, 2017
Statistical classifiers for diagnosing disease from immune repertoires: a case study using multiple sclerosisJared Ostmeyer, Scott Christley, William H Rounds, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 16, 2024
The positive predictive value of MOG-IgG testing based on the 2023 diagnostic criteria for MOGADLinda Nguyen, Sumit Singh, Fabricio S Feltrin, et al.
Orphanet Journal of Rare Diseases|December 20, 2024
Neuronal ceroid lipofuscinoses type 7 (CLN7): a case series reporting cross sectional and retrospective clinical data to evaluate validity of standardized tools to assess disease progression, quality of life, and adaptive skillsSaima Kayani, Veronica BordesEdgar, Andrea Lowden, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2013
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosisChris L Ayers, Jason P Mendoza, Sushmita Sinha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2012
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic successBenjamin M Greenberg, Donna Graves, Gina Remington, et al.
Journal of Neurology|June 21, 2024
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case reportSusan T Iannaccone, Chunyu Cai, Brittney Rhem, et al.
Neurourology and Urodynamics|November 21, 2015
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic centerLouise A Gliga, Rebecca S Lavelle, Alana L Christie, et al.
Research Square|July 9, 2024
Neuronal Ceroid Lipofuscinoses Type 7 (CLN7)- A Case Series Reporting Cross Sectional and Retrospective Clinical Data to Evaluate Validity of Standardized Tools to Assess Disease Progression, Quality of Life, and Adaptive SkillsSaima Kayani, Veronica Bordes Edgar, Andrea Lowden, et al.
Analytical Chemistry|October 1, 2013
Top-down mass spectrometry on tissue extracts and biofluids with isoelectric focusing and superficially porous silica liquid chromatographyJunmei Zhang, Michael J Roth, Audrey N Chang, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 7, 2025
Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosisShiv Saidha, John Kramer, Brandon Brown, et al.
BMC Bioinformatics|September 9, 2017
Statistical classifiers for diagnosing disease from immune repertoires: a case study using multiple sclerosisJared Ostmeyer, Scott Christley, William H Rounds, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 16, 2024
The positive predictive value of MOG-IgG testing based on the 2023 diagnostic criteria for MOGADLinda Nguyen, Sumit Singh, Fabricio S Feltrin, et al.
Orphanet Journal of Rare Diseases|December 20, 2024
Neuronal ceroid lipofuscinoses type 7 (CLN7): a case series reporting cross sectional and retrospective clinical data to evaluate validity of standardized tools to assess disease progression, quality of life, and adaptive skillsSaima Kayani, Veronica BordesEdgar, Andrea Lowden, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2013
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosisChris L Ayers, Jason P Mendoza, Sushmita Sinha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2012
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic successBenjamin M Greenberg, Donna Graves, Gina Remington, et al.
Journal of Neurology|June 21, 2024
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case reportSusan T Iannaccone, Chunyu Cai, Brittney Rhem, et al.
Neurourology and Urodynamics|November 21, 2015
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic centerLouise A Gliga, Rebecca S Lavelle, Alana L Christie, et al.
Research Square|July 9, 2024
Neuronal Ceroid Lipofuscinoses Type 7 (CLN7)- A Case Series Reporting Cross Sectional and Retrospective Clinical Data to Evaluate Validity of Standardized Tools to Assess Disease Progression, Quality of Life, and Adaptive SkillsSaima Kayani, Veronica Bordes Edgar, Andrea Lowden, et al.
Analytical Chemistry|October 1, 2013
Top-down mass spectrometry on tissue extracts and biofluids with isoelectric focusing and superficially porous silica liquid chromatographyJunmei Zhang, Michael J Roth, Audrey N Chang, et al.
Pageof 14